Results 171 to 180 of about 4,502 (202)

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

Annals of Oncology, 2006
H J Schmoll, M S Aapro, H -K Kim
exaly  

Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting

Cancer Chemotherapy and Pharmacology, 2008
Tomoya Ohno, Yasuo Kodama
exaly  

Aprepitant

Reactions Weekly, 2014
openaire   +1 more source

Aprepitant

2018
openaire   +1 more source

Aprepitant Capsules

2022
openaire   +1 more source

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting

Cancer, 2003
Alexandra D Carides, Judith K Evans, Kevin J Horgan   +2 more
exaly  

Tolerability of Fosaprepitant and Bioequivalency to Aprepitant in Healthy Subjects

Journal of Clinical Pharmacology, 2007
Judith K Evans, M Gail Murphy
exaly  

Determination of solubility of Aprepitant (an antiemetic drug for chemotherapy) in supercritical carbon dioxide: Empirical and thermodynamic models

Journal of Supercritical Fluids, 2017
Gholamhossein Sodeifian, Seyed Ali Sajadian   +1 more
exaly  

Aprepitant.

2011
openaire   +1 more source

Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder

Biological Psychiatry, 2006
G Frank Liu, Richard Hargreaves, Jarmo Hietala   +2 more
exaly